vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $18.3M, roughly 1.9× ROCKWELL MEDICAL, INC.). Clearfield, Inc. runs the higher net margin — -1.8% vs -3.0%, a 1.2% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-2.4M). Over the past eight quarters, Clearfield, Inc.'s revenue compounded faster (-3.5% CAGR vs -10.1%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CLFD vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $18.3M |
| Net Profit | $-614.0K | $-554.0K |
| Gross Margin | 33.2% | 21.1% |
| Operating Margin | -5.3% | -2.2% |
| Net Margin | -1.8% | -3.0% |
| Revenue YoY | -3.2% | -25.6% |
| Net Profit YoY | 67.8% | 26.7% |
| EPS (diluted) | $-0.04 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $18.3M | ||
| Q3 25 | $23.4M | $15.9M | ||
| Q2 25 | $49.9M | $16.1M | ||
| Q1 25 | $47.2M | $18.9M | ||
| Q4 24 | $29.7M | $24.7M | ||
| Q3 24 | $5.6M | $28.3M | ||
| Q2 24 | $48.8M | $25.8M | ||
| Q1 24 | $36.9M | $22.7M |
| Q4 25 | $-614.0K | $-554.0K | ||
| Q3 25 | $-9.1M | $-1.8M | ||
| Q2 25 | $1.6M | $-1.5M | ||
| Q1 25 | $1.3M | $-1.5M | ||
| Q4 24 | $-1.9M | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $-447.0K | $343.0K | ||
| Q1 24 | $-5.9M | $-1.7M |
| Q4 25 | 33.2% | 21.1% | ||
| Q3 25 | 53.2% | 14.3% | ||
| Q2 25 | 30.5% | 15.6% | ||
| Q1 25 | 30.1% | 16.1% | ||
| Q4 24 | 29.2% | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | 21.9% | 17.6% | ||
| Q1 24 | 7.7% | 13.5% |
| Q4 25 | -5.3% | -2.2% | ||
| Q3 25 | 10.3% | -9.9% | ||
| Q2 25 | 3.0% | -8.4% | ||
| Q1 25 | 0.6% | -7.2% | ||
| Q4 24 | -6.9% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | -4.7% | 2.0% | ||
| Q1 24 | -26.4% | -5.8% |
| Q4 25 | -1.8% | -3.0% | ||
| Q3 25 | -38.8% | -11.0% | ||
| Q2 25 | 3.2% | -9.3% | ||
| Q1 25 | 2.8% | -8.0% | ||
| Q4 24 | -6.4% | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | -0.9% | 1.3% | ||
| Q1 24 | -16.0% | -7.6% |
| Q4 25 | $-0.04 | $-0.01 | ||
| Q3 25 | $-0.65 | $-0.05 | ||
| Q2 25 | $0.11 | $-0.05 | ||
| Q1 25 | $0.09 | $-0.04 | ||
| Q4 24 | $-0.13 | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | $-0.04 | $0.01 | ||
| Q1 24 | $-0.40 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $37.0M |
| Total Assets | $268.1M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $10.7M | ||
| Q3 25 | $106.0M | $13.6M | ||
| Q2 25 | $117.2M | $12.5M | ||
| Q1 25 | $112.0M | $11.4M | ||
| Q4 24 | $113.0M | $15.7M | ||
| Q3 24 | $129.0M | $12.3M | ||
| Q2 24 | $123.8M | $11.9M | ||
| Q1 24 | $142.9M | $6.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $37.0M | ||
| Q3 25 | $256.2M | $37.0M | ||
| Q2 25 | $264.5M | $30.4M | ||
| Q1 25 | $265.9M | $31.5M | ||
| Q4 24 | $267.4M | $32.6M | ||
| Q3 24 | $275.8M | $29.1M | ||
| Q2 24 | $274.6M | $23.5M | ||
| Q1 24 | $279.2M | $20.6M |
| Q4 25 | $268.1M | $57.1M | ||
| Q3 25 | $306.2M | $57.5M | ||
| Q2 25 | $314.7M | $52.6M | ||
| Q1 25 | $310.9M | $54.0M | ||
| Q4 24 | $303.2M | $59.2M | ||
| Q3 24 | $315.3M | $57.1M | ||
| Q2 24 | $318.1M | $53.0M | ||
| Q1 24 | $315.4M | $50.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $2.3M |
| Free Cash FlowOCF − Capex | $-2.4M | $2.2M |
| FCF MarginFCF / Revenue | -7.1% | 12.0% |
| Capex IntensityCapex / Revenue | 2.9% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $7.9M | $1.8M | ||
| Q1 25 | $3.0M | $-3.5M | ||
| Q4 24 | $7.2M | $865.0K | ||
| Q3 24 | $22.2M | $4.3M | ||
| Q2 24 | $4.0M | $1.4M | ||
| Q1 24 | $-5.7M | $-2.4M |
| Q4 25 | $-2.4M | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | $7.5M | $1.7M | ||
| Q1 25 | $654.0K | $-3.5M | ||
| Q4 24 | $5.1M | $470.0K | ||
| Q3 24 | $18.2M | $4.1M | ||
| Q2 24 | $2.8M | $1.2M | ||
| Q1 24 | $-7.7M | $-2.5M |
| Q4 25 | -7.1% | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | 15.1% | 10.5% | ||
| Q1 25 | 1.4% | -18.8% | ||
| Q4 24 | 17.1% | 1.9% | ||
| Q3 24 | 323.0% | 14.4% | ||
| Q2 24 | 5.8% | 4.5% | ||
| Q1 24 | -20.8% | -11.1% |
| Q4 25 | 2.9% | 0.5% | ||
| Q3 25 | 2.0% | 1.4% | ||
| Q2 25 | 0.8% | 1.0% | ||
| Q1 25 | 5.1% | 0.3% | ||
| Q4 24 | 7.0% | 1.6% | ||
| Q3 24 | 71.4% | 0.7% | ||
| Q2 24 | 2.5% | 1.1% | ||
| Q1 24 | 5.3% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
